ECL

NYSE:ECL

Ecolab

Add to Watchlist
  • Stock

252.62

+0.47%

−6.77

USD last updated 30/07 01:56:25

Last Close

259.39

29/07 22:30

Market Cap

69.47B

Beta: 1.00

Volume Today

1.77M

Avg: 1.18M

PE Ratio

45.46

PFCF: 32.87

Dividend Yield

1.10%

Payout:50.38%

Five analysts upgraded stocks of Ecolab, Brown & Brown, Aon, Peloton Interactive, and PNC Financial Services Group, raising price targets and changing ratings from Neutral/Hold to Outperform/Buy. Stock prices closed at varying levels on Tuesday.

benzinga.com

The article discusses the Hospital Disinfection Systems Market, highlighting its projected growth from USD 3.6 billion in 2025 to USD 6.1 billion by 2032, driven by advancements in UV-C, hydrogen peroxide vapor, and electrostatic spray technologies. Key trends include the adoption of automated disinfection systems in 40% of new hospitals, a 30% reduction in hospital-acquired infections, and rising demand for portable disinfection devices. The market is influenced by government initiatives, expanding healthcare infrastructure, and hybrid disinfection technologies combining physical and chemical methods. Leading companies like STERIS, Getinge, and Ecolab are diversifying their product portfolios, while AI-powered monitoring systems and eco-friendly solutions are gaining traction.

openpr.com

Ecolab (NYSE: ECL) reported second quarter EPS of $1.89, missing the analyst estimate of $1.90, but revenue matched consensus expectations of $4.02B. The company provided guidance for Q3 2025 EPS of $2.02-$2.12 and FY 2025 EPS of $7.42-$7.62. Its stock closed at $269.99, up 5.72% in 3 months and 17.97% in 12 months.

uk.investing.com

Ecolab reported second-quarter earnings slightly below Wall Street expectations, with revenue in line with estimates. The company highlighted strong performance in Life Sciences and its digital business, reiterated full-year profit guidance, and noted margin gains from pricing and cost management. Shares traded flat at $270 pre-market.

au.investing.com

Ecolab reported second-quarter earnings slightly below Wall Street expectations, with revenue in line with estimates. The company highlighted strong performance in Life Sciences and its digital business, reiterated full-year profit guidance in-line with consensus, and maintained third-quarter earnings expectations. CEO Christophe Beck emphasized confidence in growth drivers despite macroeconomic uncertainty.

ca.investing.com

    Description

    Ecolab Inc. provides water, hygiene, and infection prevention solutions and services in the United States and internationally. The company operates through Global Industrial, Global Institutional & Specialty, and Global Healthcare & Life Sciences segments. The Global Industrial segment offers water treatment and process applications, and cleaning and sanitizing solutions to man...Show More

    Earnings

    Earnings per Share (Estimate*)

    0.511.52017-02-212019-02-192021-02-162023-02-142024-08-06

    Revenue (Estimate*)

    1B2B3B4B2017-02-212019-02-192021-02-162023-02-142024-08-06

    *Estimate based on analyst consensus